Skip to content

PharmEasy CEO hopes to return to market with an IPO if robust performance sustains

The company is awaiting Competition Commission of India (CCI) approval for the rights issue.

Read More

​ The company is awaiting Competition Commission of India (CCI) approval for the rights issue. The company is awaiting Competition Commission of India (CCI) approval for the rights issue.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish